Structure Database (LMSD)

LMSD: Structure-based search results

LM_IDCommon NameSystematic NameFormulaMassMain ClassSub Class
LMFA04020005δ11-14-NeuroF(4Z,7Z,11E)-10,13-dihydroxy-13-(4-
hydroxy-5-((Z)-pent-2-en-1-yl)
tetrahydrofuran-2-yl)trideca-4,7,11-
trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020369(10R,13R,16R)-d11-14-NeuroF[14R,17R](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2R,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020370(10R,13R,16R)-d11-14-NeuroF[14R,17S](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2R,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020371(10R,13R,16R)-d11-14-NeuroF[14S,17R](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020372(10R,13R,16R)-d11-14-NeuroF[14S,17S](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2S,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020373(10R,13R,16S)-d11-14-NeuroF[14R,17R](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2R,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020374(10R,13R,16S)-d11-14-NeuroF[14R,17S](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2R,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020375(10R,13R,16S)-d11-14-NeuroF[14S,17R](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2S,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020376(10R,13R,16S)-d11-14-NeuroF[14S,17S](4Z,7Z,10R,11E,13R)-10,13-dihydroxy-13-
((2S,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020377(10R,13S,16R)-d11-14-NeuroF[14R,17R](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2R,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020378(10R,13S,16R)-d11-14-NeuroF[14R,17S](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2R,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020379(10R,13S,16R)-d11-14-NeuroF[14S,17R](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020380(10R,13S,16R)-d11-14-NeuroF[14S,17S](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2S,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020381(10R,13S,16S)-d11-14-NeuroF[14R,17R](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2R,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020382(10R,13S,16S)-d11-14-NeuroF[14R,17S](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2R,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020383(10R,13S,16S)-d11-14-NeuroF[14S,17R](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2S,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020384(10R,13S,16S)-d11-14-NeuroF[14S,17S](4Z,7Z,10R,11E,13S)-10,13-dihydroxy-13-
((2S,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020385(10S,13R,16R)-d11-14-NeuroF[14R,17R](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2R,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020386(10S,13R,16R)-d11-14-NeuroF[14R,17S](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2R,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020387(10S,13R,16R)-d11-14-NeuroF[14S,17R](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020388(10S,13R,16R)-d11-14-NeuroF[14S,17S](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2S,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020389(10S,13R,16S)-d11-14-NeuroF[14R,17R](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2R,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020390(10S,13R,16S)-d11-14-NeuroF[14R,17S](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2R,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020391(10S,13R,16S)-d11-14-NeuroF[14S,17R](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2S,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020392(10S,13R,16S)-d11-14-NeuroF[14S,17S](4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-
((2S,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020393(10S,13S,16R)-d11-14-NeuroF[14R,17R](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2R,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020394(10S,13S,16R)-d11-14-NeuroF[14R,17S](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2R,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020395(10S,13S,16R)-d11-14-NeuroF[14S,17R](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020396(10S,13S,16R)-d11-14-NeuroF[14S,17S](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2S,4R,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020397(10S,13S,16S)-d11-14-NeuroF[14R,17R](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2R,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020398(10S,13S,16S)-d11-14-NeuroF[14R,17S](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2R,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020399(10S,13S,16S)-d11-14-NeuroF[14S,17R](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2S,4S,5R)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]
LMFA04020400(10S,13S,16S)-d11-14-NeuroF[14S,17S](4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-
((2S,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-
1-yl)tetrahydrofuran-2-yl)trideca-4,7,
11-trienoic acid
C22H34O6394.2355Docosanoids [FA04]Neurofurans [FA0402]